Exploratory Cohort Study of Depressive Symptoms in South Africans with HIV-1 Subtype C: Associations with Kynurenine Pathway Metabolites and Inflammatory Markers

Background: Depression is common in people living with HIV and may involve immune–metabolic dysregulation. Altered tryptophan (Trp) metabolism via the kynurenine (Kyn) pathway, particularly quinolinic acid (QUIN), has been linked to neuroinflammation and depression, yet data from South Africans with HIV-1 subtype C are limited. Methods: In this exploratory cohort, treatment-naïve adults with HIV were assessed at baseline in 2010 (n = 69) and followed up in 2015 (n = 40). Targeted LC-MS/MS quantified Trp–Kyn metabolites (Trp, Kyn, KA, QUIN) and ELISAs measured immune markers (suPAR, IL-6, hsCRP, sCD163, NGAL). Depressive symptoms were evaluated using the PHQ-9 at baseline and follow-up. Results: Baseline QUIN was associated with the PHQ-9 total score (adjusted R²=0.245; β=0.417; p = 0.004, p(Hochberg) = 0.044) and also increased odds of depression risk (OR=61.1; 95%CI 2.24–1664.76; p = 0.015, p(Hochberg) = 0.030) at baseline. Baseline NGAL was significantly lower in the follow-up group with self-harm thoughts compared to the group with no–self-harm thoughts (p = 0.008) and lower NGAL predicted greater odds of follow-up self-harm thoughts (OR = 0.007, 95% CI: